Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D Martin1, Horacio Cabral1, Triantafyllos Stylianopoulos2
1Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Bunkyo, Tokyo, Japan.
Combining nanomedicine and immunotherapy shows promise for cancer treatment. Strategies normalizing the tumor microenvironment can enhance drug delivery and reduce immune suppression, potentially improving patient outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Immunotherapy
- Tumor Microenvironment (TME) research
Background:
- Approved nanotherapeutics offer modest survival benefits in cancer.
- Immunotherapy has revolutionized cancer treatment but benefits a limited patient population.
- Both nanomedicines and immunotherapies face challenges due to the tumor microenvironment (TME).
Purpose of the Study:
- To explore TME normalization strategies that enhance nanomedicine delivery and immunotherapy efficacy.
- To propose a combined nanomedicine-based TME normalization and immunotherapy approach.
- To identify a minimal combination therapy to broaden immunotherapy benefits in cancer patients.
Main Methods:
- Review of TME normalization strategies.
- Discussion of combined nanomedicine and immunotherapy approaches.
- Analysis of the cancer-immunity cycle in relation to therapeutic strategies.
Main Results:
- TME normalization can simultaneously improve nanomedicine delivery and reduce tumor immunosuppression.
- Combined strategies targeting the TME hold potential to overcome limitations of individual therapies.
- A minimal combination approach could increase the number of cancer patients benefiting from immunotherapy.
Conclusions:
- TME normalization is a promising strategy for enhancing cancer nanomedicine and immunotherapy.
- Combining nanomedicine-based TME normalization with immunotherapy offers a synergistic therapeutic potential.
- This approach could significantly expand the clinical utility of immunotherapy in diverse cancer types.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

